USD 4.4
(2.56%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 14.58 Million USD | 43.49% |
2022 | 10.16 Million USD | -49.43% |
2021 | 20.09 Million USD | 36.61% |
2020 | 14.7 Million USD | 122.92% |
2019 | 6.59 Million USD | -20.32% |
2018 | 8.28 Million USD | -40.74% |
2017 | 13.97 Million USD | 742.75% |
2016 | 1.65 Million USD | 9.9% |
2015 | 1.5 Million USD | -50.45% |
2014 | 3.04 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 16.52 Million USD | 13.3% |
2024 Q2 | 16.19 Million USD | -2.0% |
2023 FY | 14.58 Million USD | 43.49% |
2023 Q4 | 14.58 Million USD | -14.5% |
2023 Q3 | 17.05 Million USD | 28.25% |
2023 Q2 | 13.29 Million USD | -3.2% |
2023 Q1 | 13.73 Million USD | 35.17% |
2022 Q3 | 12.15 Million USD | -16.51% |
2022 Q4 | 10.16 Million USD | -16.41% |
2022 FY | 10.16 Million USD | -49.43% |
2022 Q1 | 17.97 Million USD | -10.54% |
2022 Q2 | 14.56 Million USD | -19.0% |
2021 Q3 | 17.45 Million USD | -1.41% |
2021 Q2 | 17.7 Million USD | -15.36% |
2021 FY | 20.09 Million USD | 36.61% |
2021 Q1 | 20.92 Million USD | 42.24% |
2021 Q4 | 20.09 Million USD | 15.1% |
2020 Q3 | 15.35 Million USD | 19.71% |
2020 FY | 14.7 Million USD | 122.92% |
2020 Q4 | 14.7 Million USD | -4.21% |
2020 Q2 | 12.82 Million USD | -19.38% |
2020 Q1 | 15.91 Million USD | 141.14% |
2019 Q2 | 8.54 Million USD | -23.04% |
2019 Q3 | 6.08 Million USD | -28.79% |
2019 FY | 6.59 Million USD | -20.32% |
2019 Q4 | 6.59 Million USD | 8.48% |
2019 Q1 | 11.09 Million USD | 34.03% |
2018 Q4 | 8.28 Million USD | -23.54% |
2018 Q1 | 15.08 Million USD | 7.95% |
2018 FY | 8.28 Million USD | -40.74% |
2018 Q2 | 13.06 Million USD | -13.38% |
2018 Q3 | 10.83 Million USD | -17.11% |
2017 Q3 | 5.95 Million USD | -23.95% |
2017 Q2 | 7.83 Million USD | 232.13% |
2017 FY | 13.97 Million USD | 742.75% |
2017 Q1 | 2.35 Million USD | 42.27% |
2017 Q4 | 13.97 Million USD | 134.53% |
2016 Q2 | 1.32 Million USD | 0.0% |
2016 FY | 1.65 Million USD | 9.9% |
2016 Q1 | - USD | -100.0% |
2016 Q4 | 1.65 Million USD | 0.0% |
2015 FY | 1.5 Million USD | -50.45% |
2015 Q4 | 1.5 Million USD | 0.0% |
2015 Q3 | 1.5 Million USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 FY | 3.04 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Abbott Laboratories | 73.21 Billion USD | 99.98% |
Allurion Technologies Inc. | 71.71 Million USD | 79.666% |
Artivion, Inc. | 792.39 Million USD | 98.16% |
Avanos Medical, Inc. | 1.69 Billion USD | 99.138% |
Butterfly Network, Inc. | 304.27 Million USD | 95.208% |
Butterfly Network, Inc. | 304.27 Million USD | 95.208% |
Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 99.881% |
Boston Scientific Corporation | 35.13 Billion USD | 99.958% |
CONMED Corporation | 2.3 Billion USD | 99.366% |
Edwards Lifesciences Corporation | 9.36 Billion USD | 99.844% |
Paragon 28, Inc. | 340.69 Million USD | 95.72% |
Glaukos Corporation | 940.41 Million USD | 98.449% |
Globus Medical, Inc. | 5.08 Billion USD | 99.713% |
Inspire Medical Systems, Inc. | 676.81 Million USD | 97.846% |
Integer Holdings Corporation | 2.94 Billion USD | 99.504% |
Medtronic plc | 89.98 Billion USD | 99.984% |
Nevro Corp. | 635.71 Million USD | 97.706% |
Owlet, Inc. | 44.12 Million USD | 66.952% |
Penumbra, Inc. | 1.55 Billion USD | 99.063% |
Vicarious Surgical Inc. | 119.86 Million USD | 87.835% |
Smith & Nephew plc | 9.98 Billion USD | 99.854% |
Sonendo, Inc. | 78.16 Million USD | 81.344% |
STERIS plc | 11.06 Billion USD | 99.868% |
Stryker Corporation | 39.91 Billion USD | 99.963% |
Vapotherm, Inc. | 77.61 Million USD | 81.213% |
Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 99.932% |